PETS  Petmed Express Inc.




Health Care


Medical/Nursing Services

Market Cap.


Vuru Grade


Current Price

+0.00 (+0.00%)

Growth Price

Overvalued by 10.20%

Stability Price

Undervalued by 15.00%

Company Metrics

  • P/E 17.01
  • P/S 1.5
  • P/B 4.31
  • EPS 1
  • Cash ROIC 73.11%
  • Cash Ratio 6.90
  • Dividend 0.72 / 4.25%
  • Avg. Vol. 175,237.00
  • Shares 20.15M
  • Market Cap. 341.66M

Company Description

PetMed Express, Inc., doing business as 1-800-PetMeds, markets non-prescription and prescription pet medications; and other health products for dogs, cats, and horses. The company's non-prescription medications include flea and tick control products, bone and joint care products, vitamins and nutritional supplements, and hygiene products. Its prescription medications comprise heartworm preventativ... more

Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow


Petmed Express Inc (PETS): Are Hedge Funds Right About This Stock?
Insider Monkey (blog) - 21 hours ago
Petmed Express Inc (NASDAQ:PETS) investors should be aware of a decrease in hedge fund sentiment lately. The level and the change in hedge fund popularity aren't the only variables you need to analyze to decipher hedge funds' perspectives.
Petmed Express Inc (PETS) Files Form 4 Insider Selling : Ronald J Korn Sells ...
Insider Trading Report - Nov 24, 2015
Petmed Express Inc (PETS): Ronald J Korn , director of Petmed Express Inc sold 1,000 shares on Nov 20, 2015. The Insider selling transaction was disclosed on Nov 24, 2015 to the Securities and Exchange Commission.
A Director at Petmed Express (NASDAQ: PETS) is Selling Shares - Analyst Ratings
Company Shares of PetMed Express, Inc. (NASDAQ:PETS) Rally 5.86%
Insider Trading Report - Nov 23, 2015
Shares of PetMed Express, Inc. (NASDAQ:PETS) rose by 5.86% in the past week and 2.69% for the last 4 weeks. In the past week, the shares have outperformed the S&P 500 by 2.51% and the outperformance increases to 2% for the last 4 weeks.
Petmed Express (PETS) to Release Earnings on Tuesday - Dakota Financial News
PetMed Express Inc. Reports 18% Gain In Q2 Profit
Nasdaq - Oct 19, 2015
Analysts had expected the company to earn $0.20 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
Company Shares of PetMed Express, Inc. (NASDAQ:PETS) Rally 0.18% - Insider Trading Report
PetMed Express - In Decline With No Signs Of Turnaround - Seeking Alpha
Petmed Express Inc (NASDAQ:PETS) Hedge Funds Sentiment Index Up in Q2 2015 - Nov 14, 2015
Petmed Express Inc (NASDAQ:PETS) hedge funds sentiment decreased to 1.18 in Q2 2015. Its down -0.60, from 1.78 in 2015Q1. The sentiment has dropped, as 71 active investment managers opened new or increased stock positions, while 60 trimmed and ...
PetMed Express Inc (NASDAQ:PETS) on Watch
Street Report - Jul 21, 2015
[Globe Newswie] PetMed Express Inc (NASDAQ:PETS)(TREND ANALYSIS) announced its financial results for the quarter ended June 30, 2015.
Petmed Express Inc (PETS): A Hidden Health Care Gem
ETF Daily News - May 14, 2015
According to the company, it's the largest pet pharmacy in the country. PetMed Express is a very attractive dividend stock, because it offers a 4.3% dividend yield.
PetMed Express Inc.: A Small Cap With 30%+ Upside Potential (PETS)
Seeking Alpha (registration) - Sep 30, 2014
PetMed Express (NASDAQ:PETS) is a leader in online and telephone sales of pet medications. The company operates in two segments: Over-the-Counter (OTC) medication and Prescription (Rx) medication.
Company Shares of PetMed Express, Inc. (NASDAQ:PETS) Drops by -6.57%
OTC Outlook - Nov 16, 2015
PetMed Express, Inc. (NASDAQ:PETS) has lost 6.57% during the past week and dropped 1.58% in the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 3.05%.
Company Shares of PetMed Express, Inc. (NASDAQ:PETS) Rally 0.66%
OTC Outlook - Nov 1, 2015
Shares of PetMed Express, Inc. (NASDAQ:PETS) rose by 0.66% in the past week and 3.06% for the last 4 weeks. The shares have outperformed the S&P 500 by 0.45% in the past week but underperformed the index by 3.28% in the last 4 weeks.